NCT04197986 2024-03-13PROOF302QED Therapeutics, a BridgeBio companyPhase 3 Terminated39 enrolled 31 charts
NCT02538471 2019-12-09LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast CancerWeill Medical College of Cornell UniversityPhase 2 Terminated3 enrolled 11 charts